The presence of Birbeck granules or CD1a antigen positivity is the gold standard for the diagnosis of LCH.[10] Another study revealed that a significant proportion of LCH patients have BRAF V600E gene mutations, and BRAF V600E measurement of pathologic tissues is helpful for diagnosis and differential diagnosis.[11]. This evidence concerns the gene CD1A and Langerhans cell histiocytosis.